No Underlying Cause: A Case of a Fatal Neuroendocrine Lung Tumor
Main Article Content
Abstract
A 34 year old female with metastasizing neuroendocrine lung carcinoma with no underlying etiologies. Patient was diagnosed with stage 4 lung neuroendocrine cancer with treatment options limited due to intellectual disability and overall poor prognosis. The patient had a rapid decline over a 5 week period with decreased intake, decreased appetite, and overall azotemia and resulted in patient’s death.
Downloads
Article Details
Copyright (c) 2019 Dennison A, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Dasari A, Shen C, Halperin D (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3: 1335-1342. Link: https://bit.ly/2ZAkeUd
Thomas C, Jett J, Strosberg J (2018) Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging. UpToDate. Link: https://bit.ly/2x1zMUN
Rekhtman N (2010) Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med 134: 1628-1638. Link: https://bit.ly/2XXNWlL
Travis WD, Brambilla E, Burke AP, Marx A, Nicolson AG (2015) WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. Lyon, France: International Agency for Research on Cancer.
Gustafsson BI, Kidd M, Chan A (2008) Bronchopulmonary neuroendocrine tumors. Cancer 113: 5-21. Link: https://bit.ly/2Ipo1xO
Saqi A, Alexis D, Remotti F, Bhagat G (2005) Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol 123: 394-404. Link: https://bit.ly/2ZwEjL3
Travis WD (2014) Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine. Thoracic Surg Clin 24: 257-266. Link: https://bit.ly/2ZuSJeP
Thomas C, Jett J, Strosberg J (2018) Lung neuroendocrine (carcinoid) tumors: Treatment and prognosis. UpToDate. Link: https://bit.ly/2IXJBZx